Eylea (generic: aflibercept) is a prescription medication for the treatment of people with wet age-related macular degeneration (wAMD, a common eye disease associated with aging) and macular edema. Eylea belongs to a group of drugs called vascular endothelial growth factor A (VEGF-A) antagonists and placental growth factor (PlGF) antagonists. It works by inhibiting a protein that stimulates growth of new blood vessels and blood vessel leakage.

This medication comes in an injectable form to be given directly into the eye by a healthcare provider.

Common side effects of Eylea include eye redness and pain, blood spots on the whites of eyes, and cataracts.